Fenofibric Acid 135 mg / 1 Capsule 90 Capsule, Delayed Release

Reference details for licensed healthcare facility review and verification.

Fenofibric Acid NDC Family 69315-0282 Fenofibric Acid 135 mg / 1

NDC 11	69315-0282-09
Product NDC	69315-0282
Generic Drug Name	Fenofibric Acid
Brand Name	Fenofibric Acid
Manufacturer	Leading Pharma, LLC
Strength	135 mg / 1
Dosage Form	Capsule
Drug Type	Oral
Package Quantity	90 Capsule, Delayed Release
Package Description	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (69315-282-09)
Active Ingredients	Fenofibric Acid
Marketing Category	ANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Fenofibric Acid 135 mg / 1 Capsule is tracked under NDC 69315-0282-09 and rolls up into product family 69315-0282. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 90 Capsule, Delayed Release.
Manufacturer: Leading Pharma, LLC.
Dosage form: Capsule.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Review the generic familyFenofibric Acid

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 9 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubFenofibric acid 135 mg / 1 Capsule delayed release 90 Capsule, Delayed Release Bottle9 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Fenofibric Acid 135 mg / 1 Capsule 90 Capsule, Delayed Release, NDC 69315-0282-09, is a Leading Pharma, LLC 135 mg / 1 capsule presentation packaged as 90 Capsule, Delayed Release.

NDC search formats

Canonical NDC 11: 69315-0282-09
Digits-only NDC 11: 69315028209
Possible 10-digit display formats: 69315-282-09 (6931528209), 69315-0282-9 (6931502829)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links

Search by brand name: Fenofibric Acid
NDC 11: 69315-0282-09
Product family NDC: 69315-0282
VA classification code: CV350
VA classification code description: ANTILIPEMIC AGENTS
CMOP ID: F0430
VUID: 4028323